Colitis Study: Ozanimod Tops Adalimumab, Equals Vedolizumab Colitis Study: Ozanimod Tops Adalimumab, Equals Vedolizumab

In a statistical comparison, ozanimod matched vedolizumab and beat adalimumab for ulcerative colitis.Medscape Medical News
Source: Medscape Gastroenterology Headlines - Category: Gastroenterology Tags: Gastroenterology News Source Type: news